Risk vs Rewardworst case scenario I see is we get no approval’s from either HC or FDA and DM simply continue to build on its Nexalogy AI/ML.Maybe we’d go sub 10 cents but not likely for long.
Best case...both approvals and also increased signings for our AI technology.I hate floating numbers but it’s really not hard to see DM trade north of $1/share.
From all the DD many of us have done here it’s easy to see the Reward far outweighs the Risk.